User Image

Dr. Tanmoy Kumar Mandal

Consultant - Medical Oncology
MBBS | DTCD | MD (General Medicine) | DM (Medical Oncology) | DNB (Medical Oncology)
Experience: 16 Years
Languages: • Bengali • English • Hindi
Oncology
3.5

Manipal Hospital, Dhakuria - Kolkata, India

• Specialises in diagnosing and treating various malignant disorders affecting the digestive system
including the oesophagus
stomach
intestines
and associated organs
enhancing patient outcomes.
• Proficient in managing lung cancers using Immunoth

• European Society of Medical Oncologists (ESMO)
• Indian Society of Medical and Paediatric Oncologists (ISMPO)
• American Society of Clinical Oncologists (ASCO)
• Immune-Oncological Society of India (IOSI)

• Real-world Eligibility for Treatment-Free Remission in Chronic Myeloid Leukaemia Patients-Report from a Tertiary Cancer Centre in India
presented at the International CML Conference-2017 (iCMLf)
• Long-term and short-term outcomes in patients of chronic myeloid leukaemia treated with generic and innovator imatinib- a retrospective analysis
presented at the International CML Conference-2017 (iCMLf)
• Outcomes of Chronic Myeloid Leukemia-Chronic Phase Patients Treated with Generic Imatinib- Report from Tata Memorial Hospital
oral presentation in Annual meeting of Mumbai Hematology Group
March 2018
• Trastuzumab Emtansine in HER2 positive metastatic breast cancer: A real-world experience
E poster in ASCO- 2018
ASCO Abstract #226633
• Chemotherapy-Induced Anemia / Zydus Cadila- Desidustat
Phase 1
Principal Investigator
2021 - Clinical Trial
• Non-small cell lung carcinoma / Pfizer- ICON PLC- Dacomitinib
Phase 4
Principal Investigator
2021- Ongoing Clinical Trial
• Breast / Ovarian / Prostate Cancer (NATCO Pharma / CBCC Global)- Olaparib
BA/BE
Principal Investigator
2021 - Ongoing
• Prostate Cancer/ Pfizer- ICON PLC- Talazoparib
Phase 3
Principal Investigator
2021
• Renal Cell Carcinoma/ Axis Clinicals- Sunitinib
BA/BE
Principal Investigator
2021- Ongoing
• Relapsed multiple myeloma- Carfilzomib- Amgen
Phase 4
Principal Investigator
2021- Ongoing
• SPEAR Registry- Novartis- PIK3CA testing observational
Principal Investigator
2021- Ongoing

About Me

• Dr. Tanmoy Kumar Mandal is a renowned medical oncologist practising at Manipal Hospitals, Dhakuria, Kolkata. He completed his MBBS from N.R.S Medical College, Kolkata, followed by an M.D. in General Medicine from Calcutta National Medical College, Kolkata. He further earned a specialisation by pursuing a D.M. in Medical Oncology from Tata Memorial Hospital, Mumbai. Additionally, he holds an MRCP in the field of Medical Oncology (Specialty Certificate Examination) and accomplished it in the year 2019, in the same year, he derived his ESMO certification, making him a certified practising consultant medical oncologist henceforth. He has also completed his Diploma in Tuberculosis and Chest Diseases (DTCD) and a DNB in Medical Oncology, further broadening his expertise in respiratory and oncological conditions. • Dr. Mandal specialises in the treatment of oncological and haematological disorders, managing solid tumours like gastrointestinal, genitourinary, lung, head and neck, gynaecological, breast cancers, and haematological malignancies like acute leukaemias, multiple myeloma, and lymphomas. His treatment modalities include Chemotherapy, Hormonal Therapy, Biological Therapy, or other targeted treatments. He has also been part of many clinical trials. • An incredibly dedicated professional, and titled to be the best medical oncologist in Kolkata, Dr. Mandal is widely known for his skills and commitment to the field of oncology. His dedication is reflected through several poster presentations and published papers, which have gained him praise from various national and international forums. Dr. Mandal is committed to helping cancer patients with accurate diagnoses and effective treatment plans to ensure swift recovery. His patients appreciate his compassion and dedication to providing quality treatment.

Write a review for Dr. Tanmoy Kumar Mandal

Please Login to add review